Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Anthem Biosciences Private Limited, is an unlisted private company incorporated on 13 June, 2006. It is classified as a private limited company and is located in , Karnataka. It's authorized share capital is INR 125.00 cr and the total paid-up capital is INR 114.10 cr.
Anthem Biosciences's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 24.14% over the previous year. At the same time, it's book networth has increased by 28.49%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Ravikant Uppal | 00025970 | 1 years |
Managing Director | Ajay Bhardwaj
Shareholder
|
00333704 | 19 years |
Director | Ganesh Sambasivam
Shareholder
|
01469963 | 19 years |
Director | K Ravindra Chandrappa
Shareholder
|
01580534 | 19 years |
Nominee Director | Satish Chander Subbanna | 02849420 | 4 years |
Director | Shubha Kulkarni | 03551350 | 1 years |
Director | Subramanian Madhavan | 06451889 | 1 years |
Director | Ramesh Ramadurai | 07109252 | 1 years |
Kmp | Mohammed Gawir Baig | <HIDDEN> | 2 years |
Kmp | Divya Prasad | <HIDDEN> | 1 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
The Federal Bank Limited
No. of Loans: 1
Total Amount : 204.0 cr
CitiBank N.A.
No. of Loans: 2
Total Amount : 199.5 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 25.0 cr
BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCIL
No. of Loans: 1
Total Amount : 11.2 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
NEOANTHEM LIFESCIENCES PRIVATE LIMITED | Karnataka | 2020 | ₹ 15.0 L |
Read more
The incorporation date of ANTHEM BIOSCIENCES PRIVATE LIMITED is 13 June, 2006
The authorized share capital of ANTHEM BIOSCIENCES PRIVATE LIMITED is INR ₹ 125.0 Cr.
The paid-up capital of ANTHEM BIOSCIENCES PRIVATE LIMITED is INR ₹ 114.1 Cr.
The registered address of ANTHEM BIOSCIENCES PRIVATE LIMITED is NO. 49, F1 & F2, CANARA BANK ROAD BOMMASANDRA INDUSTRIAL AREA, PHASE I, BO MMASANDRA NA BANGALORE Bangalore Karnataka - 560099
The CIN number of ANTHEM BIOSCIENCES PRIVATE LIMITED is U24233KA2006PTC039703.